ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Infinimmune raised $75 million in Series A funding. The financing round supports the company's development of its antibody discovery platform. The funding details were disclosed in the announcement.
Tap to vote and see what everyone thinks.
Summary by ByteBrief